Nicola Squillace
Overview
Explore the profile of Nicola Squillace including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
854
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Monforte A, Tavelli A, Quiros-Roldan E, Fabbiani M, Ferrara M, Caputo S, et al.
HIV Med
. 2024 Dec;
26(3):489-499.
PMID: 39618291
Rationale: Doravirine (DOR) is an attractive new option both for ART-naïve people with HIV (PWH) and those with suppressed HIV-RNA who seek treatment simplification. We used real-world data to examine...
2.
De Socio G, Ricci E, Piconi S, Squillace N, Maggi P, Orofino G, et al.
AIDS
. 2024 Oct;
39(2):143-152.
PMID: 39434586
Objective: The study aimed to assess the impact of smoking exposure on major clinical events (MCEs) in a real-life setting of people with HIV (PWH). Design: An observational, longitudinal, multicenter...
3.
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort
Soria A, Graziano F, Ghilardi G, Lapadula G, Dalla Gasperina D, Benatti S, et al.
Heliyon
. 2024 Sep;
10(16):e36102.
PMID: 39247344
Objective: Monoclonal antibodies (mAbs) against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) reduced Coronavirus Disease 2019 (COVID-19) hospitalizations in people at risk of clinical worsening. Real-world descriptions are limited. Methods:...
4.
Monti B, Soria A, Saladini F, Lapadula G, Squillace N, Giammarino F, et al.
J Med Virol
. 2024 Jul;
96(8):e29832.
PMID: 39056225
No abstract available.
5.
Pipito L, Ricci E, Maggi P, De Socio G, Pellicano G, Trizzino M, et al.
Viruses
. 2024 May;
16(5).
PMID: 38793658
Background: The coexistence of HIV infection and latent tuberculosis infection (LTBI) presents a significant public health concern due to the increased risk of tuberculosis (TB) reactivation and progression to active...
6.
Corti N, Menzaghi B, Orofino G, Guastavigna M, Lagi F, Di Biagio A, et al.
Viruses
. 2024 Apr;
16(4).
PMID: 38675955
Cardiovascular disease (CVD) is common in people with HIV (PWH), and has great impact in terms of morbidity and mortality. Several intertwined mechanisms are believed to play a role in...
7.
Bartalucci C, Baldi F, Ricci E, Orofino G, Menzaghi B, Ferrara S, et al.
AIDS
. 2024 Feb;
38(3):430-434.
PMID: 38300162
Injectable cabotegravir and rilpivirine long-acting therapy is a revolutionary new antiretroviral treatment (ART) option for HIV infection in virologically suppressed adults on a stable ART. The aim of this study...
8.
Bruzzesi E, Gabrieli A, Bernasconi D, Marchetti G, Calcagno A, Ripamonti D, et al.
J Med Virol
. 2023 Sep;
95(9):e29114.
PMID: 37752816
As the introduction of antiretroviral therapy (ART) during primary HIV-1 infection (PHI) could restrict the establishment of HIV reservoirs, we aimed to assess the effect of three different ART regimens...
9.
Faverio P, Paciocco G, Tassistro E, Rebora P, Rossi E, Monzani A, et al.
Intern Emerg Med
. 2023 Sep;
19(1):183-190.
PMID: 37715857
Short- and medium-term cardio-pulmonary sequelae after COVID-19 have been extensively studied. However, studies with longer follow-ups are required. This study aims to identify and characterise cardio-pulmonary sequelae, in patients hospitalised...
10.
Squillace N, Ricci E, Maggi P, Taramasso L, Menzaghi B, De Socio G, et al.
PLoS One
. 2023 Aug;
18(8):e0289132.
PMID: 37556481
Introduction: Integrase strand transfer inhibitors (INSTI) are one of the most prescribed drug classes for the treatment of HIV infection worldwide. Emtricitabine/Tenofovir Alafenamide/ Bictegravir (FTC/TAF/BIC) has been evaluated in randomized...